Organon & Co.
Pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Organon & Co.?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.[4] Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Organon & Co. is an example of increasing women's representation on Wall Street with over 50% of its board of directors and executive leadership being female.[5]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Industry | Pharmaceuticals |
Predecessor | Organon International (founded 1923)[1] |
Founded | 2020; 4 years ago (2020)[2] |
Headquarters | 30 Hudson Street, , U.S. |
Key people | Kevin Ali (CEO) |
Revenue | US$6.26 billion (2023) |
US$1.26 billion (2023) | |
US$1.02 billion (2023) | |
Total assets | US$12.1 billion (2023) |
Total equity | US$ā70 million (2023) |
Number of employees | c.ā10,000 (2023) |
Website | organon |
Footnotes / references [3] |
Close